Abstract
Thermal sensitivity of tumors depends on a number of physiological parameters such as tumor pH and metabolic status. Therefore, efforts to improve the efficacy of hyperthermia treatments have led to attempts to manipulate these various physiological factors either directly or indirectly. The parameters most often studied have been tumor pH and tumor blood flow. Tumor blood flow will influence tumor temperatures achieved during the treatment, as well as oxygen and nutrient delivery to the tumor and waste byproduct removal from the tumor that can ultimately impact on tumor pH. Thus, manipulation of tumor blood flow can affect many physiological parameters in the tumor. This chapter will cover some of the methods and results used to manipulate these physiological parameters.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ashby BS (1966) pH studies in human malignant tumors. Lancet II: 312–315
Burney IA, Maxwell RJ, Griffiths JR, Field SB (1991) The potential for prazosin and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours. Br J Cancer 64: 683–688
Chan RC, Babbs CF, Vetter RJ, Lamar CH (1984) Abnormal response of tumor vasculature to vasoactive drugs. J Natl Cancer Inst 72: 145–150
Chu GL, Dewey WC (1988) The role of low intracellular pH or extracellular pH in sensitization to hyperthermia. Radiat Res 114: 154–167
Chu GL, Wang Z, Hyun WC, Pershadshigh HA, Fulwyler JJ, Dewey WC (1990) The role of intracellular pH and its variance in low pH sensitization of killing by hyperthermia. Radiat Res 122: 288–293
Cook JA, Fox MH (1988) Effects of chronic pH 6.6 on growth, intracellular pH, and response to 42.0°C hyperthermia of Chinese Hamster Ovary cells. Cancer Res 48: 2417–2420
Cragoe EJ Jr (1987) Drugs for the treatment of traumatic brain injury. Med Res Rev 7: 271–305
Dewhirst MW, Prescott DM, Clegg S et al. (1990) The use of hydralazine to manipulate tumor temperatures during hyperthermia. Int J Hyperthermia 6: 971–983
Dipette DJ, Ward-Hartley KA, Jain RK (1986) Effect of glucose on systemic hemodynamics and blood flow rate in normal and tumor tissues in rats. Cancer Res 46: 6299–6304
Field SB, Burney IA, Needham S, Maxwell RJ, Griffiths JR (1994) From hydralazine to CGRP to man? Int J Hyperthermia 10: 451–455
Hahn GM, Shiu EC (1986) Adaptation to low pH modifies thermal and thermochemical responses to mammalian cells. Int J Hyperthermia 2: 379–387
Haveman J (1979) The pH of the cytoplasm as an important factor in the survival of in vitro cultured malignant cells after hyperthermia. Effects of carbonylcyanide 3-chlorophenylhydrazone. Eur J Cancer 15: 1281–1288
Haveman J, Hahn GM (1981) The role of energy in hyperthermia-induced mammalian cell inactivation: a study of the effects of glucose starvation and an uncoupler of oxidative phosphorylation. J Cell Physiol 107: 237–241
Hofer KG, Mivechi NF (1980) Tumor cell sensitivity to hyperthermia as a function of extracellular and intracellular pH. J Natl Cancer Inst 65: 621–625
Gerweck LE (1977) Modification of cell lethalilty at elevated temperatures: the pH effect. Radiat Res 70: 224–235
Gerweck LE, Rottinger E (1976) Enhancement of mammalian cell sensitivity to hyperthermia by pH alteration. Radiat Res 67: 508–511
Griffiths JR (1991) Are cancer cells acidic? Br J Cancer 64: 425–427
Jahde E, Volk T, Atema A, Smets LA, Glusenkamp KH, Rajewsky MF (1992) pH in human tumor xenografts and transplanted rat tumors: effect of insulin, inorganic phosphate, and m-iodobenzylguanidine. Cancer Res 52: 6209–6215
Jirtle RL (1988) Chemical modification of tumour blood flow. Int J Hyperthermia 4: 355–371
Kim JH, Kim SH, Alfievi AA, Young CW (1984) Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of HeLa cells. Cancer Res 44: 102–106
Kim GE, Lyons JC, Song CW (1991) Effects of amiloride on intracellular pH and thermosensitivity. Int J Radiat Oncol Biol Phys 20: 541–549
Krag DN, Storm FK, Morton DL (1990) Induction of transient hyperglycaemia in cancer patients. Int J Hyperthermia 6: 741–744
Leeper DB, Engin K, Thistlethwaite AJ, Hitchon HD, Dover JD, Li D-J, Tupchong L (1994) Human tumor extracellular pH as a function of blood glucose concentration. Int J Radiat Oncol Biol Phys 28: 935–943
Lyons JC, Kim GE, Song CW (1992) Modification of intracellular pH and thermosensitivity. Radiat Res 129: 79–87
Lyons JC, Ross BD, Song CW (1993) Enhancement of hyperthermia effect in vivo by amiloride and DIDS. Int J Radiat Oncol Biol Phys 25: 95–103
Mahnensmith RL, Aronson PS (1985) The plasma membrane sodium-hydrogen exchange and its role in physiological and pathophysiological processes. Circ Res 56: 773–788
Miyakoshi J, Oda W, Hirata M, Fukuhori N, Inagaki C (1986) Effects of amiloride on thermosensitivity of Chinese hamster cells under neutral and acidic pH. Cancer Res 46: 1840–1843
Nielson OS, Overgaard J (1979) Effect of extracellular pH on thermotolerance and recovery of hyperthermic damage in vitro. Cancer Res 39: 2772–2778
Prescott DM, Samulski TV, Dewhirst MW, Page RL, Thrall DE, Dodge RK, Oleson JR (1992) Use of nitroprusside to increase tissue temperature during local hyperthermia in normal and tumor-bearing dogs. Int J Radiat Oncol Biol Phys 23: 377–385
Prescott DM, Charles HC, Sostman HD et al. (1993) Manipulation of intra-and extracellular pH in spontaneous canine tumours by use of hyperglycaemia. Int J Hyperthermia 9: 745–754
Roemer RB, Forsyth K, Oleson JR, Clegg ST, Sim DA (1988) The effect of hydralazine dose on blood perfusion changes during hyperthermia. Int J Hyperthermia 4: 401–415
Roos A, Boron WF (1981) Intracellular pH. Physiol Rev 61: 296–434
Ruifrok ACC, Konings AWT (1987) Effects of amiloride on hyperthermic cell killing of normal and thermotolerant mouse fibroblast LM cells. Int J Radiat Biol 52: 385–392
Schulz V (1984) Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate, and thiocyanate. Clin Pharmacokinet 9: 239–251
Song CW, Lyons JC, Griffin RJ, Makepeace CM (1993a) Thermosensitization by lowering intracellular pH with EIPA. Radiother Oncol 27: 252–258
Song CW, Lyons JC, Griffin RJ, Makepeace CM, Cragoe EJ Jr (1993b) Increase in thermosensitivity of tumor cells by lowering intracellular pH. Cancer Res 53: 1599–1601
Song CW, Lyons JC, Makepeace CM, Griffin RJ, Cragoe EJ Jr (1994) Effects of HMA, an analog of amiloride, on the thermosensitivity of tumors in vivo. Int J Radiat Oncol Biol Phys 30: 133–139
Struthers AD, Brown MJ, MacDonald DWR, Beacham JL, Stevenson JC, Morris HR, Maclntyre I (1986) Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci 70: 389–393
Tannock IF, Rotin D (1989) Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49: 4373–4384
Thistlethwaite AJ, Alexander GA, Moylan DJ, Leeper DB (1987) Modification of human tumor pH by elevation of blood glucose. Int J Radiate Oncol Biol Phys 13: 603–610
Varnes ME, Glazier KG, Gray C (1989) pH-dependent effects of the ionophore nigericin on response of mammalian cells to radiation and heat treatment. Radiat Res 117: 282–292
Vaupel PW, Okunieff PG (1988) Role of hypovolemic hemoconcentration in dose-dependent flow decline observed in murine tumors after intraperitoneal administration of glucose or mannitol. Cancer Res 48: 7102–7106
Vigne P, Félin C, Audinot M, Borsotto M, Cragoe EJ Jr, Lazdunski M (1984) [3H]Ethylpropylamiloride, a radiolabelled diuretic for the analysis of the Na+/H+ exchange system. Its use with kidney cell membranes. EMBO J 3: 2647–2651
von Ardenne M, Kell E (1979) Berechnung des dynamischen Aufheizprozesses in mehrschichtigen Modellgeweben bei Lokalhyperthermie nach dem CMT-Selectotherm-Verfahren. Arch Geschwulstforsch 49: 590–612
von Ardenne M, Reitnauer PG (1980) Selective occlusion of cancer tissue capillaries as the central mechanism of the cancer multistep therapy. Jpn J Clin Oncol 10: 31–48
Voorhees WD, Babbs CF (1982) Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. Eur J Cancer Clin Oncol 18: 1027–1034
Walker HJ, Geniton DJ (1989) Vasodilator therapy and the anesthetist: a review of nitroprusside, labetalol, hydralazine and nitroglycerin. J Am Assoc Nurse Anesthetists 57: 435–444
Ward KA, Jain PK (1988) Response of tumours to hyperglycaemia: characterization, significance and role in hyperthermia. Int J Hyperthermia 4: 223–250
Ward KA, Jain RK (1991) Blood flow response to hyperglycemia. In: Vaupel P, Jain RK (eds) Tumor blood supply and metabolic microenvironment: characterization and implications for therapy. Gustav Fischer, Stuttgart, pp 87–107
Ward KA, Dipette DJ, Held TN, Jain RK (1991) Effect of i.v. versus i.p. glucose injection on systemic hemodynamics and blood flow rate in normal and tumor tissue in rats. Cancer Res 51: 3612–3616
Zhuang YX, Cragoe EJ Jr, Glaser JS, Cassel D (1984) Characterization of potent Na+/H+ exchange inhibitors from the amiloride series in A431 cells. Biochemistry 23: 4481–4488
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Prescott, D.M. (1995). Manipulation of Physiological Parameters During Hyperthermia. In: Seegenschmiedt, M.H., Fessenden, P., Vernon, C.C. (eds) Thermoradiotherapy and Thermochemotherapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57858-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-57858-8_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63382-9
Online ISBN: 978-3-642-57858-8
eBook Packages: Springer Book Archive